Ultrasonic Spray Nozzles Industry Expertise Products Company Investors Customer Reviews
  • Categories >>
  • Electronics
  • Energy
  • Medical
  • Glass
  • Food
  • Textiles
  • Nanotechnology
  • Industrial
  • Categories >>
  • Electronics
  • Energy
  • Medical
  • Glass
  • Food
  • Textiles
  • Nanotechnology
  • Industrial
test

Sono-Tek To Host Third Quarter Of Fiscal Year Earnings Call

(January 12, 2015 – Milton, NY) – On Thursday, January 15, 2014 at 10:00 a.m. (EST), Sono-Tek Corporation will hold a conference call to discuss the company’s third quarter results and forecasts for the fourth fiscal quarter and preliminary sales targets for FY2016.

To join the conference, please call 1-626-544-0058, the access code is 241-728-870.

If you would like to submit questions during the conference call, please register at:
https://attendee.gotowebinar.com/register/8186272351339714306. After registering, you will receive a confirmation email from GoToWebinar containing information about joining the conference call. Listeners on the call may ask questions of management only by inputting them from their computers.

For further information, contact Dr. Christopher L. Coccio, at 845-795-2020, or visit our website at www.sono-tek.com

Sono-Tek Corporation is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology. Founded in 1975, the Company’s products have long been recognized for their performance, quality, and reliability.

This earnings release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting our operations or the demand for our products; timely development and market acceptance of new products; adequacy of financing; capacity additions, the ability to enforce patents, acceptance of our advanced medical device platform; continued penetration into the U.S. and European food coating and solar energy markets, maintenance of order backlog, consummation of order proposals, continued sales strength in stent coating, semiconductor and PCB fluxing, stability of overseas markets and the ability to achieve increased sales volume at projected levels and continued profitability. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.